DMS, a BRMi Company, Supporting COVID-19 Response and Research

//DMS, a BRMi Company, Supporting COVID-19 Response and Research

DMS, a BRMi Company, Supporting COVID-19 Response and Research

The importance of our national and global health hasn’t been so widely evident as it has during the COVID-19 pandemic. For almost 40 years, BRMi’s DMS division has dedicated themselves to supporting the work of biomedical researchers and public health organizations, using our expertise in the information sciences to help reduce the pain and suffering related to cancer, HIV/AIDS, and other infectious diseases.

The COVID-19 pandemic is no different, and DMS employees are once again in the rear guard of this public health emergency. Whether working remotely to continue to support essential research into cancer, applying our analytics expertise in novel ways to understand and combat the implications of the COVID-19 pandemic, or putting ourselves at risk to provide on-site technology support to NIH researchers, BRMi remains dedicated to protecting the nation’s health and safety.

By | 2020-04-02T10:01:20+00:00 April 2nd, 2020|Uncategorized|Comments Off on DMS, a BRMi Company, Supporting COVID-19 Response and Research

About the Author: